BackQSAM Biosciences Overview

QSAM Biosciences Accounts Payable

Track QSAM Biosciences's accounts payable ($570K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$569851.00
23.51% YoYΔ $-175160.00 vs prior year quarter

Peer average

Loading

QSAM Biosciences Accounts Payable History

Loading

QSAM Biosciences vs. peers: Accounts Payable Comparison

Loading

QSAM Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

QSAM Biosciences (QSAM) FAQ

As of the most recent data (December 2023), QSAM shows a accounts payable of $570K. That compares with $750K in the prior-year period — down 23.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, QSAM's accounts payable is now $570K (was $750K) — a 23.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether QSAM Biosciences is outperforming or lagging.

Tracking QSAM's accounts payable over time shows whether QSAM Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $570K That compares with $750K in the prior-year period — down 23.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has QSAM Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $570K) with ownership activity and broader fundamentals.

QSAM Biosciences's accounts payable is $570K; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.